Nurse Practitioner · Sacramento, CA
NPI
1255448957
Since 2006
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
980 Florin Rd
Sacramento, CA, 95831
Phone (916) 453-5142
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$3.0M
23,348 prescriptions
Company payments, 2025
$812
From 14 companies
Medicare prescription drug claims, 2024
In 2024, the drug Kevin H Vuong prescribed most often to Medicare patients was Losartan Potassium, with 1,448 prescriptions and refills. In total Kevin H Vuong wrote 23,348 Medicare prescriptions that cost $3.0M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-07-27.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Losartan Potassium Generic | 1,448 | 4,159 | 419 | $18K |
| Amlodipine Besylate Generic | 1,328 | 3,768 | 402 | $10K |
| Atorvastatin Calcium Generic | 1,151 | 3,335 | 336 | $15K |
| Metformin Hcl Generic | 880 | 2,451 | 244 | $8,641 |
| Simvastatin Generic | 767 | 2,236 | 207 | $6,409 |
| Alendronate Sodium Generic | 747 | 2,004 | 221 | $6,062 |
| Tamsulosin Hcl Generic | 628 | 1,811 | 201 | $12K |
| Azelastine Hcl Generic | 567 | 1,499 | 306 | $21K |
| Metoprolol Succinate Generic | 555 | 1,531 | 172 | $9,462 |
| Jardiance Empagliflozin | 539 | 874 | 119 | $494K |
| Montelukast Sodium Generic | 511 | 1,396 | 242 | $7,746 |
| Pravastatin Sodium Generic | 496 | 1,404 | 143 | $6,358 |
| Lisinopril Generic | 490 | 1,366 | 136 | $3,605 |
| Gabapentin Generic | 456 | 916 | 198 | $5,241 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 408 | 466 | 189 | $14K |
Brand drugs: 3,411 claims; generic drugs: 19,811 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kevin H Vuong $812 ($812 in general payments such as food, travel and fees) from 14 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $143.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 6 | $143 |
| Novo Nordisk Inc NVO | 2 | $142 |
| Amgen Inc. AMGN | 5 | $94.9 |
| Gilead Sciences, Inc. GILD | 3 | $76.72 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $65.31 |
| Aimmune Therapeutics, Inc. | 2 | $49.57 |
| GlaxoSmithKline, LLC. GSK | 2 | $47.04 |
| Pfizer Inc. PFE | 1 | $40.24 |
| Janssen Biotech, Inc. JNJ | 1 | $36.45 |
| Exact Sciences Corporation EXAS | 1 | $33.48 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.